MedPath

Clinical trial to study the effects of two drugs cisatracurium and rocuronium in paediatric patients undergoing routine surgeries under general anaesthesia

Phase 4
Conditions
Health Condition 1: J989- Respiratory disorder, unspecified
Registration Number
CTRI/2024/02/062258
Lead Sponsor
Dr R Deepak
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

patients undergoing elective surgical procedures under general anaesthesia between 2 to 12 years of age and between 10 kg to 40 kg body weight

Exclusion Criteria

patients refusal,ASA grade 3 and 4 ,age below 2 years and above 12 years,weight below 10 kg and above 40 kg,patient with disorders of cardiovascular,hepatic,renal or neuromuscular system and epilepsy,pt with airway problems suggestive of difficult intubation,patients with know history of drug allergy

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
rocuronium has rapid onset and produces excellent to good intubating conditions than cisatracuriumTimepoint: 24 hours
Secondary Outcome Measures
NameTimeMethod
no adverse effects noted with both cisatracurium and rocuroniumTimepoint: 24 hours
© Copyright 2025. All Rights Reserved by MedPath